Predicted Long-Term Antibody Persistence for a Tick-Borne Encephalitis Vaccine: Results From a Modeling Study Beyond 10 Years After a Booster Dose Following Different Primary Vaccination Schedules

Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2019.1700712
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Immune Persistence 17 to 20 Years After Primary Vaccination With Recombination Hepatitis B Vaccine (CHO) and the Effect of Booster Dose Vaccination

BMC Infectious Diseases
Infectious Diseases
2019English

Points: Vaccination Against Tick-Borne Encephalitis

BMJ
1982English

Age Affects Quantity but Not Quality of Antibody Responses After Vaccination With an Inactivated Flavivirus Vaccine Against Tick-Borne Encephalitis

PLoS ONE
Multidisciplinary
2012English

Fatal Outcome of European Tick-Borne Encephalitis After Vaccine Failure

Frontiers in Neurology
Neurology
2017English

Persistence of Bactericidal Antibodies Following Early Infant Vaccination With a Serogroup B Meningococcal Vaccine and Immunogenicity of a Preschool Booster Dose

CMAJ
Medicine
2013English

Antibody Persistence in Pre-School Children After Hexavalent Vaccine Infant Primary and Booster Administration

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

Long-Term Protection Against Diphtheria in the Netherlands After 50 Years of Vaccination: Results From a Seroepidemiological Study

PLoS ONE
Multidisciplinary
2016English

Antibody Persistence After a Single Dose of Quadrivalent HPV Vaccine and the Effect of a Dose of Nonavalent Vaccine Given 3-8 Years Later – An Exploratory Study

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

Tick-Borne Encephalitis

2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy